profile

This Week in RadOnc

This Week in RadOnc is your weekly guide to the research, technology, and industry developments shaping radiation oncology curated for clinicians, technologists, and industry professionals.

Featured Post

This Week in RadOnc - Vol. 3, October 16th, 2026

Volume 3, October 16th, 2026 Welcome back to This Week in Rad Onc! This week’s evidence asks where precision adds value—and where promising technology still needs validation. ROAM strengthens the discussion of postoperative radiation for atypical meningioma, while ASTRO updates bring longer follow-up and important cautions about toxicity, crossover and local control. For treatment teams, new CBCT and electron-dosimetry studies sit alongside practical motion-management guidance. We also...

Volume 2, October 1st, 2026 Welcome back to This Week in Rad Onc! This week, we continue unpacking ASTRO’s findings, with a focus on shorter treatment courses, patient experience, and the evidence needed to bring new approaches into everyday practice. I’m particularly interested in how these developments affect the entire care team and patient outcomes. Alongside the research, you’ll find industry and reimbursement updates, a case spotlight, and recruiting trials in a more accessible format....

TWiRO at ASTRO 2026

First Edition - October 1st, 2026 Welcome to the first edition of This Week in Rad Onc, affectionately known as TWiRO. My name is Michael Owens. After attending ASTRO for the tenth time this year, I spoke with several colleagues who hadn't heard some of the biggest clinical and industry news announced at the meeting. It made me realize there was a need for a consolidated, trusted source covering both the clinical and industry developments that matter to those of us working in and around the...